Furthermore, Dammeijer et al. reported that targeting CD8 + T cells only in the draining lymph nodes but not within the tumor (where CD8 + T cells are exhausted) with α-PD-1 treatment improved CD8 + T cell tumor infiltration and suppressed tumor size [29]. The gene discussed is CD8A; the disease is neoplasm.